Analysis of doctors’ awareness of the fever correction principles in children
Keywords:ibuprofen, acetaminophen, children, survey
Background. Fever in children is one of the most common causes for parents to see a doctor. The purpose was to analyze the state of awareness of doctors about the fever treatment principles in children, the methods of optimal dosage of antipyretic drugs and features of the antipyretic therapy use in certain categories of patients by means of specially designed questionnaires. Materials and methods. One hundred eight doctors took part in the survey. The questionnaire consisted of 20 questions. Results. Doctors note that only 66.0 % of parents use the means recommended by the doctor to reduce the body temperature in their children, the rest rely on personal experience and recommendations of pharmacists. 64.2 % of respondents indicated ibuprofen as a first-line antipyretic drug. 90.6 % of doctors believed an increase in body temperature to 38.5 °C or more to be an indication for the use of antipyretic drugs. However, 26.4 % of doctors use this group of drugs after vaccination; 17.0 % of respondents admit the use of antipyretic drugs at a child’s body temperature less than 38.5 °C, especially with a history of febrile convulsions, as well as pain syndrome and poor health. 50.9 % of respondents combine the use of acetaminophen and ibuprofen if one of them is ineffective, using the second drug in the intervals between taking the first one. The most difficult questions for doctors were the peculiarities of the use of antipyretic drugs in children with comorbidities. Conclusions. Given the findings of the survey, we consider it necessary to conduct further work among physicians on awareness of the principles and indications for the use of antipyretic therapy in children.
Matok I, Elizur A, Perlman A, Ganor S, Levine H, Kozer E. Association of Acetaminophen and Ibuprofen Use With Wheezing in Children With Acute Febrile Illness. Ann Pharmacother. 2017;51(3):239-244. doi: 10.1177/1060028016678006.
Marushko YuV. Prevention and therapy of frequent and recurrent respiratory diseases in children is a topical issue of pediatrics. Sovremennaya pediatriya. 2006;2:32-36.
Fields E, Chard J, Murphy MS, Richardson M; Guideline Development Group and Technical Team. Assessment and initial management of feverish illness in children younger than 5 years: summary of updated NICE guidance. BMJ. 2013 May 22;346:f2866. doi: 10.1136/bmj.f2866.
de Bont EG, Francis NA, Dinant GJ, Cals JW. Parents' knowledge, attitudes, and practice in childhood fever: an internet-based survey. Br J Gen Pract. 2014 Jan;64(618):e10-6. doi: 10.3399/bjgp14X676401.
Bertille N, Fournier-Charriere E, Pons G, Chalumeau M. Managing fever in children: a national survey of parents' knowledge and practices in France. PLoS One. 2013 Dec 31;8(12):e83469. doi: 10.1371/journal.pone.0083469.
Luo S, Ran M, Luo Q, et al. Alternating Acetaminophen and Ibuprofen versus Monotherapies in Improvements of Distress and Reducing Refractory Fever in Febrile Children: A Randomized Controlled Trial. Paediatr Drugs. 2017 Oct;19(5):479-486. doi: 10.1007/s40272-017-0237-1.
Community Paediatrics Committee. Fever Temperature Taking. Available from: https://www.caringforkids.cps.ca/handouts/fever_and_temperature_taking.
American Academy of Pediatrics Healthy Children. Fever (2012). Available from: https://www.healthychildren.org/English/health-issues/conditions/fever/Pages/default.aspx. Accessed: January 31, 2013.
NICE Guidance. Fever in under 5s: assessment and initial management. Available from: https://www.nice.org.uk/guidance/cg160. Accessed: 22 May 2013.
Green R, Jeena P, Kotze S, Lewis H, Webb D, Wells M. Management of acute fever in children: Guideline for community healthcare providers and pharmacists. S Afr Med J. 2013 Sep 3;103(12):948-54. doi: 10.7196/samj.7207.
Playne R, Anderson BJ, Frampton C, Stanescu I, Atkinson HC. Analgesic effectiveness, pharmacokinetics, and safety of a paracetamol/ibuprofen fixed-dose combination in children undergoing adenotonsillectomy: A randomized, single-blind, parallel group trial. Paediatr Anaesth. 2018 Dec;28(12):1087-1095. doi: 10.1111/pan.13517.
Chung AM. An evaluation of community pharmacy recommendations regarding alternating antipyretics in children. J Am Pharm Assoc (2003). 2018 Jul 21. pii: S1544-3191(18)30320-0. doi: 10.1016/j.japh.2018.06.015.
Chiappini E, Principi N, Longhi R, et al. Management of fever in children: summary of the Italian Pediatric Society guidelines. Clin Ther. 2009 Aug;31(8):1826-43. doi: 10.1016/j.clinthera.2009.08.006.
Bertille N, Purssell E, Hjelm N, et al. Symptomatic Management of Febrile Illnesses in Children: A Systematic Review and Meta-Analysis of Parents' Knowledge and Behaviors and Their Evolution Over Time. Front Pediatr. 2018 Oct 5;6:279. doi: 10.3389/fped.2018.00279.
Marushko YuV. Nurofen® for children: questions and answers. Kyiv: Interservis; 2017. 78 p.
Beasley RW, Clayton TO, Crane J, et al. Acetaminophen use and risk of asthma, rhinoconjunctivitis, and eczema in adolescents: International Study of Asthma and Allergies in Childhood Phase Three. Am J Respir Crit Care Med. 2011 Jan 15;183(2):171-8. doi: 10.1164/rccm.201005-0757OC.
Wickens K, Beasley R, Town I, et al. The effects of early and late paracetamol exposure on asthma and atopy: a birth cohort. Clin Exp Allergy. 2011 Mar;41(3):399-406. doi: 10.1111/j.1365-2222.2010.03610.x.
Sordillo JE, Scirica CV, Rifas-Shiman SL, et al. Prenatal and infant exposure to acetaminophen and ibuprofen and the risk for wheeze and asthma in children. J Allergy Clin Immunol. 2015 Feb;135(2):441-8. doi: 10.1016/j.jaci.2014.07.065.
Walsh P, Rothenberg SJ. Wheezing after the use of acetaminophen and or ibuprofen for first episode of bronchiolitis or respiratory tract infection. PLoS One. 2018 Sep 13;13(9):e0203770. doi: 10.1371/journal.pone.0203770.
Gulmez SE, Unal US, Lassalle R, Chartier A, Grolleau A, Moore N. Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: Preliminary results from the EPIHAM study. Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1174-1181. doi: 10.1002/pds.4640.
Copyright (c) 2019 Yu.V. Marushko, T.V. Hyshchak
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.